A Slovakian study performed MLPA analyses in 39 tumor samples of high-grade serous ovarian cancer and detected one pathogenic BRCA1 deletion (2.6%) [25]. The gene discussed is BRCA1; the disease is ovarian serous adenocarcinoma.